Market Estimates
Valuation Metrics
Financials
Trading Trends
LRMR News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Larimar Therapeutics Inc (LRMR) stock price today?
The current price of LRMR is 3.36 USD — it has decreased -1.75 % in the last trading day.
What is Larimar Therapeutics Inc (LRMR)'s business?
Larimar Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide (CPP) technology platform. The Company’s lead product candidate, nomlabofusp, is a subcutaneously administered, recombinant fusion protein intended to deliver tissue frataxin (FXN), an essential protein, to the mitochondria of patients with Friedreich's ataxia (FA). FA is a rare, progressive, and fatal disease in which patients are unable to produce sufficient FXN due to a genetic abnormality. Its CPP platform, which enables a therapeutic molecule to cross a cell membrane in order to reach intracellular targets, has the potential to enable the treatment of other rare and orphan diseases. The Company intends to use its proprietary platform to target additional orphan indications characterized by deficiencies in or alterations of intracellular content or activity.
What is the price predicton of LRMR Stock?
Wall Street analysts forecast LRMR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LRMR is 18.00 USD with a low forecast of 7.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Larimar Therapeutics Inc (LRMR)'s revenue for the last quarter?
Larimar Therapeutics Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.
What is Larimar Therapeutics Inc (LRMR)'s earnings per share (EPS) for the last quarter?
Larimar Therapeutics Inc. EPS for the last quarter amounts to -0.61 USD, increased 154.17 % YoY.
What changes have occurred in the market's expectations for Larimar Therapeutics Inc (LRMR)'s fundamentals?
How many employees does Larimar Therapeutics Inc (LRMR). have?
Larimar Therapeutics Inc (LRMR) has 65 emplpoyees as of January 09 2026.
What is Larimar Therapeutics Inc (LRMR) market cap?
Today LRMR has the market capitalization of 279.18M USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251218212125_95e817f04e0cf0cdef52405f6b420fb0.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F00e67f192e6427ce53357b22076df296f11dbc2b8856e4e30a66942949d516c4.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2Fea2ed14951846a450e8e5bbbfba5fb5d64f550532ba552e255fe0f8169517ba2.png&w=384&q=75)